Advertisement

Topics

Lundbeck Research USA, Inc. Company Profile

15:34 EDT 23rd June 2018 | BioPortfolio

Now that scientists have mapped the human genome, new opportunities exist for developing drugs that exclusively target specific receptors associated with the symptoms and causes of a disease.Receptor-specific drugs provide a new model in drug discovery that can improve the state-of-the-art treatment for many serious and common disorders. Lundbeck Research USA uses this discovery model to pursue novel treatments for CNS diseases. Our talented scientists have achieved influential discoveries in genomics (the cloning of genes) and functional genomics (the identification of a given receptor’s physiological function), making us a world leader in G Protein-Coupled Receptor (GPCR) discovery research.
As the Research Center of Excellence for Depression and Anxiety in the United States we support our parent company, H. Lundbeck A/S. A global company headquartered in Denmark, Lundbeck is a world leader in the development of pharmaceuticals for psychiatric and neurological disorders. Research and development efforts have recently resulted in the successful development of Cipralex ® (escitalopram) – the first compound of the next-generation selective serotonin reuptake inhibitors (SSRIs).
The scientific expertise at Lundbeck Research USA will ensure the continuation of a rich pipeline of drug discovery candidates for H. Lundbeck A/S.

Location

215 College Road
Paramus
New Jersey
07652-1431
United States of America

Contact

Phone: 1 201 261 1331
Fax: 1 201 261 0623
Email: information@lundbeck.com


News Articles [67 Associated News Articles listed on BioPortfolio]

Lundbeck targets 2020 for development of partnered schizophrenia candidate

Lundbeck has acquired an exclusive license to a research program aimed at a novel approach to treating…

Lundbeck to acquire Prexton Therapeutics adding foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson's disease

H. Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) today announced signing of a definitive agreement in which Lundbeck will acquire Prexton. Under terms of the agreement, Lundbeck will p...

Lundbeck Signs Near €1Bn Acquisition of Swiss Parkinson’s Biotech

Lundbeck is acquiring Prexton Therapeutics in a deal that could reach up to €905M if the Swiss company’s Parkinson’s treatment proves successful.  Danish pharma Lundbeck has decided to ...

Lundbeck divests two preclinical research programmes to MindImmune Therapeutics

H.Lundbeck, a global pharmaceutical company specialized in psychiatric and neurological disorders, has announced that the company further focuses its preclinical research pipeline with the divestment ...

H. Lundbeck A/S: Lundbeck to acquire Prexton Therapeutics adding foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson's disease

-- Lundbeck will make an upfront payment of EUR 100 million and the deal terms also include up to EUR 805 million in development, regulatory and sales milestones -- Foliglurax is a first-in-class t...

Lundbeck partners with Vanderbilt University on schizophrenia research project

Danish pharmaceutical firm Lundbeck has signed a separate licensing and research collaboration agreement with Tennessee’s Vanderbilt University to develop a novel solution in the treatment of schizo...

H. Lundbeck A/S: Lundbeck held its Annual General Meeting on 20 March 2018 at the company's registered office

Valby, Denmark, 2018-03-20 14:01 CET (GLOBE NEWSWIRE) -- Valby, Denmark, 20 March 2018 - H. Lundbeck A/S (Lundbeck) today announced that at the Annual General Meeting the report by the Board of Dir...

Lundbeck takes risk on Parkinson’s treatment, €905m on table

CNS’ treatments are notoriously risky, especially those that are still at an early stage; however, Lundbeck has decided to take a calculated risk on Prexton Therapeutics and its sole candidate for P...

Drugs and Medications [79 Associated Drugs and Medications listed on BioPortfolio]

La mer the treatment fluid foundation [MAX HUBER RESEARCH LAB INC]

Neoprofen [Lundbeck Inc.]

These highlights do not include all the information needed to use NeoProfen safely and effectively. See full prescribing information for NeoProfen. NeoProfen (ibuprofen lysine) Injection for intraveno...

Alco-san instant skin sanitizer [Mid-American Chemical Research Corporation]

ALCO-SAN INSTANT SKIN SANITIZER

Sunscreen [CRC (Cosmoceutical Research Center)]

SUNSCREEN SPF 28/30

Vionexus [Metrex Research]

VioNexus No Rinse Spray

PubMed Articles [621 Associated PubMed Articles listed on BioPortfolio]

Increasing Residency Research Output While Cultivating Community Research Collaborations.

Having a research curriculum in addition to hosting a resident research day stimulates research activity in residency programs. Research collaborations outside an individual residency program may also...

Research matters: Meta-spin cycles, the blindness of bias, and rebuilding trust.

Meta-research is research about research. Meta-research may not be as click-worthy as a meta-pug-a pug dog dressed up in a pug costume-but it is crucial to understanding research. A particularly valua...

A consensus statement on how to conduct inclusive health research.

The active involvement of people with intellectual disabilities in research, or inclusive research, is relatively common. However, inclusive health research is less common, even though it is expected ...

Improving the process of research ethics review.

Research Ethics Boards, or Institutional Review Boards, protect the safety and welfare of human research participants. These bodies are responsible for providing an independent evaluation of proposed ...

Is the Right Research Being Conducted to Advance Knowledge about Breast Reconstruction? An Analysis of the Research Pipeline.

It has been estimated that up to 85 percent of research is of limited value or wasted, in part because of the wrong research questions being addressed. In this study, the authors identified research g...

Clinical Trials [1041 Associated Clinical Trials listed on BioPortfolio]

Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease

The purpose of this study is to investigate the utility of dopamine transporter imaging in monitoring and predicting the progression of Parkinson disease. This study will be performed in ...

Research Participants' Views on the Ethics of Clinical Research

This pilot study will explore the usefulness of a series of questions asking about views of research from the perspective of minority and economically disadvantaged research participants. ...

Clinical Research in ALS

CRiALS is an umbrella protocol through which people are recruited to participate in a range of research studies being conducted by the ALS Research Collaboration (ARC).

How Participants Perceive Biomedical Research in Pulmonology

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

GenI: a Tool to Generate Paramedical Research Ideas

In order to develop paramedical research culture, the paramedical staff need adapted tools and methods. The GenI project (Research ideas generation) has for main objective the design and v...

Companies [1036 Associated Companies listed on BioPortfolio]

Lundbeck LLC

Lundbeck in the U.S., headquartered in Deerfield, Illinois, is a wholly-owned subsidiary of H. Lundbeck A/S in Denmark. Lundbeck is committed to accelerating advances in brain dis...

Lundbeck Inc.

Lundbeck Inc. was established in March 2009 following the acquisition of Ovation Pharmaceuticals, Inc. by Lundbeck and has proven success in developing and commercializing high-ne...

Lundbeck

Depression, schizophrenia, Alzheimer's, Parkinson's, epilepsy, Multiple Sclerosis, and migraines have their foundation in the Central Nervous System - our key focus areas. Lundbeck's entire R&D effort...

Psychotropics

The Lundbeck Institute is pleased to present Psychotropics Online, a comprehensive guide to CNS compounds and products.We have published Psychotropics since the 1960s in a printed handbook version, an...

Lundbeck Limited

As a pharmaceutical manufacturer, Lundbeck is unique in that we focus solely on the treatment of diseases of the central nervous system. Our aim is to be the world leader in the development of pharmac...

More Information about "Lundbeck Research USA, Inc." on BioPortfolio

We have published hundreds of Lundbeck Research USA, Inc. news stories on BioPortfolio along with dozens of Lundbeck Research USA, Inc. Clinical Trials and PubMed Articles about Lundbeck Research USA, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lundbeck Research USA, Inc. Companies in our database. You can also find out about relevant Lundbeck Research USA, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record